Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,875.00    180.00 (2.69%)
Bid:
6,875.00
Ask:
6,880.00
Spread: 5.00 (0.073%)
Market Cap: £5.07b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Queen's Award for Enterprise

21 Apr 2015 07:00

RNS Number : 7585K
Spirax-Sarco Engineering PLC
21 April 2015
 

News Release

21st April 2015

Spirax-Sarco Engineering plc receives a Queen's Award for Enterprise in Innovation

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in niche fluid technology, has received a Queen's Award for Enterprise in Innovation - the UK's highest accolade for business success - for the design and manufacture of a unique flowmeter.

The Spirax Sarco TVA flowmeter is the revolutionary alternative to traditional steam flow measurement. The device provides reliable, accurate and cost-effective steam metering, combined with quick and easy installation, in many environments and across a range of industries worldwide, including food and beverage manufacturing, healthcare organisations, university campuses and petrochemical plants. The flowmeter uses variable area technology and incorporates a proprietary sensor and unique mathematical algorithms. One of the key benefits of the flowmeter's innovative design is an ability to measure a wide range of flow rates. With the system knowledge provided by the flowmeter, steam users can improve energy efficiency, reduce carbon emissions and cut costs.

The innovation is benefiting the Company from higher sales and global market penetration.

Nick Anderson, Chief Executive, commenting on the award said, "We are extremely proud and honoured to have received a prestigious Queen's Award for Enterprise in Innovation. This award recognises the achievements of our R&D team and Spirax Sarco's commitment to innovation, technical development and manufacturing excellence, and to providing our customers with exceptional products that help them to improve the efficiency of their steam systems."

The TVA flowmeter was developed in Cheltenham, UK and tested in our world-class technology centre and steam laboratory. The TVA flowmeter product range offers a variety of line sizes, superheat capability and self-powered or wireless communications options.

Annually, we invest around £10 million in R&D across the Group and are focused on providing products that help our customers to improve their process efficiencies and meet their sustainability targets. New products contribute meaningfully to our sales growth.

About the Queen's Award

The Queen's Awards for Enterprise are the most prestigious accolades for businesses in the United Kingdom. The winners are announced each year on 21st April, Her Majesty the Queen's birthday. The awards recognise outstanding achievements by UK companies in three categories: International Trade, Innovation and Sustainable Development. Each award is valid for five years and winners are invited to a reception with HM The Queen at Buckingham Palace.

 

Enquiries:

David Meredith, Director Finance

Tel: 01242 535234

 About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in each of its two businesses, Spirax Sarco for steam specialties and Watson-Marlow Fluid Technology Group for niche peristaltic pumps and associated fluid path technologies. The steam specialties business provides a broad range of fluid control products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. The company helps its customers to improve production efficiency, reduce energy costs, water usage and emissions, improve product quality and enhance the safety of their operations. Watson-Marlow Fluid Technology Group offers the ideal solution for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance free pumps and associated technologies. The Group is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,800 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX).

Further information can be found at www.spiraxsarcoengineering.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBUGDSRSDBGUG
Date   Source Headline
8th Jun 20261:24 pmRNSDirector/PDMR Shareholding
1st Jun 202610:28 amRNSChange in Major Shareholding
29th May 20262:24 pmRNSUpdate on Directorships held by Company Directors
27th May 20263:30 pmRNSDirector/PDMR Shareholding
26th May 20265:24 pmRNSDirector/PDMR Shareholding
19th May 20269:16 amRNSChange in Major Shareholding
14th May 20262:47 pmRNSExternal Directorships held by Company Directors
14th May 202610:39 amRNSDirector/PDMR Shareholding
13th May 20264:12 pmRNSResult of AGM
13th May 20267:00 amRNSTrading Update
8th May 20263:42 pmRNSChange in Major Shareholding
7th May 20269:03 amRNSDirector/PDMR Shareholding
8th Apr 20262:22 pmRNSDirector/PDMR Shareholding
8th Apr 20269:30 amRNSAnnual Report and Accounts 2025 and Notice of AGM
18th Mar 20264:53 pmRNSDirector/PDMR Shareholding
11th Mar 20261:53 pmRNSTotal Voting Rights
10th Mar 20265:01 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS2025 Full Year Results
10th Mar 20267:00 amRNS2025 Full Year Results
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
10th Feb 20269:30 amRNSChange in Director Details
6th Feb 20263:47 pmRNSDirector/PDMR Shareholding
2nd Feb 20261:50 pmRNSChange in Director Details
30th Jan 20262:19 pmRNSHolding(s) in Company
6th Jan 20263:10 pmRNSDirector/PDMR Shareholding
18th Dec 20252:12 pmRNSCorrection: Block Listing Application
18th Dec 20252:12 pmRNSCorrection: Block Listing Application
18th Dec 202510:34 amRNSBlocklisting Application
9th Dec 20252:35 pmRNSDirector/PDMR Shareholding
18th Nov 20259:40 amRNSDirector/PDMR Shareholding
13th Nov 20257:00 amRNSTrading Update
7th Nov 20251:56 pmRNSDirector/PDMR Shareholding
5th Nov 20258:39 amRNSHolding(s) in Company
22nd Oct 20257:00 amRNSBoard Appointment
7th Oct 20255:08 pmRNSDirector/PDMR Shareholding
9th Sep 20257:00 amRNSDirector/PDMR Shareholding
1st Sep 20259:35 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSBoard Committee Membership Update
12th Aug 20257:00 amRNS2025 Half Year Results
7th Aug 20257:00 amRNSDirector/PDMR Shareholding
24th Jul 20254:58 pmRNSDirector/PDMR Shareholding
9th Jul 20254:26 pmRNSDirector/PDMR Shareholding
13th Jun 20253:36 pmRNSDirector/PDMR Shareholding
14th May 20254:48 pmRNSResult of AGM
14th May 20257:00 amRNSTrading Update
8th May 202511:03 amRNSDirector/PDMR Shareholding
23rd Apr 20255:13 pmRNSChange in Director Details
22nd Apr 20253:52 pmRNSDirector/PDMR Shareholding
11th Apr 20255:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.